Official Title
Opt-In Versus Opt-Out for COVID Screening Assessment for Exposure
Brief Summary

In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balancing program effectiveness, feasibility, costs, and scalability. The investigators will evaluate the implementation of a COVID-19 screening program that coordinates several existing systems at the University of Pennsylvania including saliva-based viral testing and test different outreach strategies (opt-in vs opt-out) to improve program enrollment.

Detailed Description

The coronavirus disease 2019 (COVID-19) pandemic has resulted in close to 10,000,000 reported
cases worldwide, including more than 2,000,000 aggregated reported cases and 120,000 deaths
in the United States. Initial efforts to address the COVID-19 pandemic were aimed at testing
symptomatic individuals, implementing stay-in-place orders, and at increasing hospital
capacity to meet surge demands. While the US continues to confront the current crisis, we
must plan for the future by putting in place tools to enhance our ability to conduct
effective screening, containment, and case management.

Widespread COVID-19 testing is needed to safely and effectively reopen schools and businesses
across the US. However, currently approved testing options require reagents that are limited
in supply, severely hindering scalability. Emerging evidence indicates that saliva testing
with the option of at-home sample collection can accurately identify COVID-19 viral
infection. Additional diagnostic testing options will continue to increase patient access.
Moreover, this approach provides an option for the easy, safe and convenient collection of
samples required for testing without traveling to a doctor's office, hospital, or testing
site. Collection by the patient also reduces exposure of health care workers to the virus and
preserves limited personal protective equipment.

With access to expanded testing, health systems and universities will need to test
alternative methods to manage COVID-19 spread while balancing program effectiveness,
feasibility, costs, and scalability. Insights from the field of behavioral economics offer
promise for designing and sustaining these kinds of policies. Specifically, research has
demonstrated that an opt-out framed recruitment strategy compared to a conventional opt-in
strategy can improve enrollment and adherence to behavioral interventions.

For these reasons, the investigators propose to evaluate the implementation of a COVID-19
screening program that uses saliva-based testing and to test approaches to improve program
enrollment.

Completed
COVID19

Behavioral: Opt-out Recruitment Email

Behaviorally informed, opt-out framed recruitment email

Behavioral: Opt-in Recruitment Email

Standard, opt-in framed recruitment email

Eligibility Criteria

Inclusion Criteria:

•University of Pennsylvania staff, faculty, and trainees that have returned to work on
campus who have been identified by leadership at the University of Pennsylvania Perelman
School of Medicine.

Exclusion Criteria:

•Participants will not be eligible for the study if they identify any reason they are
unable to participate in the study.

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations

Penn Medicine
Philadelphia, Pennsylvania, United States

Mitesh S Patel, MD, Principal Investigator
University of Pennsylvania

University of Pennsylvania
NCT Number
Keywords
Covid-19
Coronavirus
opt-in
opt-out
behavioral science
MeSH Terms
COVID-19